Why the future of marijuana legalization remains hazy despite high public support
Cannabis legalization implementation challenges continue to create barriers between public support and actual patient access to medical cannabis. Complex regulatory frameworks and federal-state conflicts complicate clinical decision-making and treatment…
Death of Medical Cannabis Patient Highlights Ongoing Stigma in Organ Transplant Programmes
Medical cannabis organ transplant discrimination policies continue to deny life-saving care based on outdated stigma rather than clinical evidence. Transplant centers must reconcile legitimate medical cannabis therapy with evidence-based transplant…
Texas Rescinds Cresco Labs’ Awarded License for Medical Cannabis Market
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustry Why This Matters License rescissions directly affect patient access to medical cannabis products and the…
Cannabis Adult Use Zoning Study | Saint Paul Minnesota
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustry Why This Matters # Clinical RelevanceSaint Paul’s zoning regulations for cannabis retail…
Our Opinion: Pennsylvania Must Embrace Recreational Cannabis Legalization
Pennsylvania recreational cannabis legalization could significantly broaden patient access beyond current medical restrictions. This shift would impact clinical counseling and regulatory frameworks. Understanding these changes is essential for healthcare…
Trump DOJ Deregulates Marijuana to the Dismay of Health Experts – The Washington Stand
The Trump DOJ deregulates marijuana, affecting federal marijuana policy and clinical access to cannabis medicines. These changes influence patient care and research opportunities. Health experts express concern over the implications of this policy shift.
Trump Urges Congress to Amend Hemp Ban After Marijuana Reclassification
Hemp ban compliance is critical as Congress debates amendments following marijuana reclassification. These changes could affect patient access to hemp-derived cannabinoid medicines. Clinicians must stay informed about evolving hemp regulations to ensure…
Marijuana Advocacy Groups Meet State Officials After Reclassification
State cannabis reclassification impact is reshaping patient access and regulatory frameworks. Advocacy groups meet with officials to influence policy changes. These developments affect clinical practice and patient care.
DOJ Schedule III cannabis order creates uncertainty for D.C.’s medical self-certification program
The DOJ Schedule III cannabis order creates regulatory uncertainty for D.C.’s medical self-certification program. This federal scheduling change may disrupt patient access to medical cannabis. Clinicians and patients must understand the implications of…
White House and GOP Lawmaker Push 2026 Hemp Legislation Updates
2026 hemp legislation updates are shaping the future of hemp-derived THC products. These regulatory changes impact clinical practice and patient access nationwide. Understanding these updates is crucial for navigating the evolving hemp THC legal…
